Cases 11 - 20 of 91
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH IRELAND LIMITED et al v. AUROBINDO PHARMA LIMITED et al
as 2:2023cv00170
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED and SALIX PHARMACEUTICALS, INC.
Defendant:
AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA INC. and AURO PEPTIDES LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CHIESI USA INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED et al
as 1:2023cv00022
Defendant:
EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALTIES LIMITED, EUGIA US LLC and others
Plaintiff:
CHIESI USA INC. and CHIESI FARMACEUTICI S.P.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CHIESI USA INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED (A.K.A. EUGIA PHARMA SPECIALTIES LIMITED) et al
as 3:2023cv00022
Plaintiff:
CHIESI USA INC. and CHIESI FARMACEUTICI S.P.A.
Defendant:
EUGIA PHARMA SPECIALITIES LIMITED (A.K.A. EUGIA PHARMA SPECIALTIES LIMITED), EUGIA US LLC and AUROBINDO PHARMA LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED et al
as 2:2022cv03186
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant:
EUGIA PHARMA SPECIALITIES LIMITED, AUROBINDO PHARMA USA, INC., AUROMEDICS PHARMA LLC and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 1:2022cv03610
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 1:2022cv03610
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 3:2022cv03610
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al
as 3:2022cv02345
Plaintiff:
BIOMARIN PHARMACEUTICAL INC. and MERCK & CIE
Defendant:
AUROBINDO PHARMACEUTICALS LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
